A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars

NCT00825916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Scar Prevention
Scar Reduction

Interventions

DRUG: AZX100 Drug Product
DRUG: AZX100 Drug Product
DRUG: Placebo

Sponsor

Capstone Therapeutics